Clinical Scorecard: Use of Probiotics to Reduce the Risk of Necrotizing Enterocolitis in Extremely Preterm Neonates in a NICU Environment

At a Glance

Key Highlights

• Probiotic supplementation associated with approximately 50% decrease in NEC incidence among infants delivered before 30 weeks’ gestation.
• NEC mortality rates reported between 15% to 30%.
• Probiotic formulation ProPrems shown efficacy in preventing NEC in infants weighing less than 1500 g.
• Quality control measures for probiotic products are essential.
• Surveillance for probiotic-associated sepsis is necessary in NICUs.

Guideline-Based Recommendations

Diagnosis

• NEC is diagnosed based on clinical signs such as feeding intolerance, abdominal distension, and hematochezia.

Management

• Routine probiotic supplementation should be considered for NEC prevention in high-risk neonates.

Monitoring & Follow-up

• Maintain surveillance for probiotic-associated sepsis.

Risks

• Potential for probiotic-associated sepsis, particularly with low bacterial burdens.

Patient & Prescribing Data

Preterm infants in NICU settings.

Probiotic strains must have established efficacy from rigorous clinical trials.

Clinical Best Practices

• Select probiotic formulations manufactured under good manufacturing practice standards.
• Ensure strain specificity when implementing probiotics in NICUs.

Related Resources & Content

• Imren et al. Study
• ESPGHAN Recommendations
• Probiotics in Preterm Infants Study